background

Linagliptin Metabolite CD1790

Linagliptin Metabolite CD1790 Watermark

Linagliptin Metabolite CD1790

CAT No:CL-LNG-126
CAS No:NA
Mol.F:C25H27N7O3
Mol.Wt.:473.5
Chemical Name:(R)-7-(but-2-yn-1-yl)-8-(3-hydroxypiperidin-1-yl)-3-methyl-1-((4-methylquizolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione
Inventory Status:Custom synthesis

This impurity is related to Linagliptin Metabolite CD1790 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.

Linagliptin Metabolite CD1790 is used as a reference standard in analytical research. It ensures consistency of formulations.

Chemical Name:(R)-7-(but-2-yn-1-yl)-8-(3-hydroxypiperidin-1-yl)-3-methyl-1-((4-methylquizolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione
Country of Origin: India
Product Category: Impurity Reference Standard
API NAME: Linagliptin
Molecular Formula: C25H27N7O3
Molecular Weight: 473.5
Storage: Store in a cool, dry place.

Document